Annual Cash & Cash Equivalents
$35.93 M
-$21.70 M-37.65%
December 31, 2023
Summary
- As of February 8, 2025, SNTI annual cash & cash equivalents is $35.93 million, with the most recent change of -$21.70 million (-37.65%) on December 31, 2023.
- During the last 3 years, SNTI annual cash & cash equivalents has risen by +$5.39 million (+17.65%).
- SNTI annual cash & cash equivalents is now -37.65% below its all-time high of $57.62 million, reached on December 31, 2022.
Performance
SNTI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$10.48 M
-$5.38 M-33.93%
September 30, 2024
Summary
- As of February 8, 2025, SNTI quarterly cash and cash equivalents is $10.48 million, with the most recent change of -$5.38 million (-33.93%) on September 30, 2024.
- Over the past year, SNTI quarterly cash and cash equivalents has stayed the same.
- SNTI quarterly cash and cash equivalents is now -92.50% below its all-time high of $139.80 million, reached on June 30, 2022.
Performance
SNTI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SNTI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.6% | 0.0% |
| 3 y3 years | +17.6% | - |
| 5 y5 years | +17.6% | - |
SNTI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.6% | at low | -92.5% | at low |
| 5 y | 5-year | -37.6% | +17.6% | -92.5% | at low |
| alltime | all time | -37.6% | +17.6% | -92.5% | at low |
Senti Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.48 M(-33.9%) |
| Jun 2024 | - | $15.86 M(-33.1%) |
| Mar 2024 | - | $23.72 M(-34.0%) |
| Dec 2023 | $35.93 M | $35.93 M(-8.9%) |
| Sep 2023 | - | $39.43 M(+7.3%) |
| Jun 2023 | - | $36.75 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $31.60 M(-45.2%) |
| Dec 2022 | $57.62 M(+2.8%) | $57.62 M(-49.9%) |
| Sep 2022 | - | $114.94 M(-17.8%) |
| Jun 2022 | - | $139.80 M(+149.5%) |
| Dec 2021 | $56.03 M(+83.5%) | $56.03 M |
| Dec 2020 | $30.54 M | - |
FAQ
- What is Senti Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Senti Biosciences?
- What is Senti Biosciences annual cash & cash equivalents year-on-year change?
- What is Senti Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Senti Biosciences?
- What is Senti Biosciences quarterly cash and cash equivalents year-on-year change?
What is Senti Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of SNTI is $35.93 M
What is the all time high annual cash & cash equivalents for Senti Biosciences?
Senti Biosciences all-time high annual cash & cash equivalents is $57.62 M
What is Senti Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, SNTI annual cash & cash equivalents has changed by -$21.70 M (-37.65%)
What is Senti Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SNTI is $10.48 M
What is the all time high quarterly cash and cash equivalents for Senti Biosciences?
Senti Biosciences all-time high quarterly cash and cash equivalents is $139.80 M
What is Senti Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, SNTI quarterly cash and cash equivalents has changed by $0.00 (0.00%)